Tower Research Capital (TRC)’s La Jolla Pharmaceutical Company LJPC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,083
| Closed | -$7K | – | 7024 |
|
|
2022
Q2 | $7K | Sell |
2,083
-1,486
| -42% | -$5.79K | ﹤0.01% | 4884 |
|
|
2022
Q1 | $15K | Sell |
3,569
-5,183
| -59% | -$22.6K | ﹤0.01% | 3862 |
|
|
2021
Q4 | $41K | Buy |
8,752
+3,420
| +64% | +$14.3K | ﹤0.01% | 2934 |
|
|
2021
Q3 | $21K | Sell |
5,332
-1,244
| -19% | -$4.94K | ﹤0.01% | 3694 |
|
|
2021
Q2 | $28K | Sell |
6,576
-1,436
| -18% | -$6.15K | ﹤0.01% | 3588 |
|
|
2021
Q1 | $34K | Buy |
8,012
+1,650
| +26% | +$9.09K | ﹤0.01% | 3475 |
|
|
2020
Q4 | $24K | Sell |
6,362
-15,318
| -71% | -$65.5K | ﹤0.01% | 3766 |
|
|
2020
Q3 | $88K | Sell |
21,680
-3,331
| -13% | -$13.8K | ﹤0.01% | 3246 |
|
|
2020
Q2 | $106K | Buy |
+25,011
| New | +$152K | ﹤0.01% | 2404 |
|
|
2020
Q1 | – | Sell |
-8,399
| Closed | -$33K | – | 4508 |
|
|
2019
Q4 | $33K | Buy |
8,399
+8,343
| +14,898% | +$49.3K | ﹤0.01% | 1615 |
|
|
2019
Q3 | $0 | Sell |
56
-10
| -15% | -$94 | ﹤0.01% | 4902 |
|
|
2019
Q2 | $1K | Sell |
66
-4,508
| -99% | -$34K | ﹤0.01% | 3582 |
|
|
2019
Q1 | $30K | Buy |
+4,574
| New | +$29.8K | ﹤0.01% | 2061 |
|
|
2018
Q4 | – | Sell |
-4,241
| Closed | -$85K | – | 4836 |
|
|
2018
Q3 | $85K | Buy |
+4,241
| New | +$111K | 0.01% | 1452 |
|
|
2018
Q2 | – | Sell |
-12,833
| Closed | -$382K | – | 4494 |
|
|
2018
Q1 | $382K | Buy |
+12,833
| New | +$414K | 0.03% | 600 |
|
|
2017
Q4 | – | Sell |
-1,988
| Closed | -$69K | – | 4537 |
|
|
2017
Q3 | $69K | Buy |
1,988
+1,594
| +405% | +$51.3K | 0.01% | 1702 |
|
|
2017
Q2 | $12K | Sell |
394
-527
| -57% | -$15.1K | ﹤0.01% | 1550 |
|
|
2017
Q1 | $27K | Buy |
921
+51
| +6% | +$1.3K | ﹤0.01% | 1112 |
|
|
2016
Q4 | $15K | Buy |
870
+159
| +22% | +$3.05K | ﹤0.01% | 2408 |
|
|
2016
Q3 | $17K | Sell |
711
-1,595
| -69% | -$30.1K | ﹤0.01% | 1738 |
|
|
2016
Q2 | $37K | Buy |
+2,306
| New | +$41.4K | ﹤0.01% | 1782 |
|
|
2016
Q1 | – | Sell |
-230
| Closed | -$6K | – | 5855 |
|
|
2015
Q4 | $6K | Sell |
230
-554
| -71% | -$15.1K | ﹤0.01% | 2917 |
|
|
2015
Q3 | $22K | Sell |
784
-118
| -13% | -$3.72K | ﹤0.01% | 1676 |
|
|
2015
Q2 | $22K | Buy |
902
+878
| +3,658% | +$18.1K | ﹤0.01% | 2045 |
|
|
2015
Q1 | $0 | Sell |
24
-6
| -20% | -$122 | ﹤0.01% | 5645 |
|
|
2014
Q4 | $1K | Sell |
30
-248
| -89% | -$2.94K | ﹤0.01% | 3927 |
|
|
2014
Q3 | $3K | Buy |
+278
| New | +$2.77K | ﹤0.01% | 3749 |
|
|
2014
Q2 | – | Sell |
-542
| Closed | -$6K | – | 5489 |
|
|
2014
Q1 | $6K | Buy |
+542
| New | +$5.32K | ﹤0.01% | 3215 |
|
Tower Research Capital (TRC)'s LJPC Position: Q3 2022 in Review
Tower Research Capital (TRC) sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2022, closing a stake of 2,083 shares — an estimated $7K sold.
Tower Research Capital (TRC) first reported a position in LJPC in Q1 2014 and held it in 28 quarters. The position peaked at $382K in Q1 2018. 0 funds tracked by Wall St. Rank hold LJPC as of Q3 2022.
- Tower Research Capital (TRC) reported no remaining La Jolla Pharmaceutical Company position as of Q3 2022 after selling out during the quarter.
- Tower Research Capital (TRC) sold 2,083 La Jolla Pharmaceutical Company shares in Q3 2022, an estimated $7K.
- Tower Research Capital (TRC) first reported a position in La Jolla Pharmaceutical Company in Q1 2014 and held it in 28 quarters.
- Tower Research Capital (TRC)'s La Jolla Pharmaceutical Company position peaked at $382K in Q1 2018.
- 0 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2022.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.